Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release

被引:1
|
作者
Liang, Desheng [1 ]
Frank, Simon [2 ,3 ]
Schwendeman, Steven P. [1 ,4 ]
机构
[1] Univ Michigan, Biointerfaces Inst, Dept Pharmaceut Sci, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA
[2] Merck Life Sci KGaA, Darmstadt, Germany
[3] Merck KGaA, Darmstadt, Germany
[4] Univ Michigan, Dept Biomed Engn, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA
关键词
Remote loading; PLGA; Microspheres; Octreotide; Leuprolide; Controlled release; MICROENCAPSULATION; PROTEINS;
D O I
10.1007/s13346-023-01424-6
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Remote loading microencapsulation of peptides into polymer microspheres without organic solvent represents a promising alternative to develop long-acting release depots relative to conventional encapsulation methods. Here, we formulated drug-free microspheres from two kinds of uncapped poly(lactide-co-glycolides) (PLGAs), i.e., ring-opening polymerized Expansorb((R)) DLG 50-2A (50/50, 11.2 kDa) and Expansorb((R)) DLG 75-2A (75/25, 9.0 kDa), and evaluated their potential capacity to remote-load and control the release of two model peptides, leuprolide and octreotide. Degradation and erosion kinetics, release mechanism, and storage stability was also assessed. As control formulations, peptide was loaded in the same PLGA 75/25 polymer by the conventional double emulsion-solvent evaporation method (W/O/W) and remote loaded in polycondensation poly(lactic-co-glycolic acid) 75/25 (Wako 7515, 14.3 kDa). Loading content of 6.7%-8.9% w/w (similar to 67%-89% encapsulation efficiency (EE)) was attained for octreotide, and that of 9.5% w/w loading (similar to 95% EE) was observed for leuprolide, by the remote loading paradigm. Octreotide and leuprolide were both slowly and continuously released in vitro from the remote-loaded Expansorb((R)) DLG 75-2A MPs for over 56 days, which was highly similar to that observed from traditionally-loaded formulations by W/O/W (8.8% loading, 52.8% EE). The faster release kinetics was observed for the faster degrading PLGA 50/50 remote-loaded Expansorb((R)) DLG 50-2A MPs relative to microspheres from the PLGA 75/25 Expansorb((R)) DLG 75-2A. Despite slight differences in degradation kinetics, the release mechanism of octreotide from the Expansorb((R)) microspheres, whether remote loaded or by W/O/W, was identical as determined by release vs. mass loss curves. Octreotide acylation was also minimal (< similar to 10%) for this polymer. Finally, drug-free Expansorb((R)) DLG 75-2A MPs displayed excellent storage stability over 3 months. Overall, this work offers support for the use of ring-opening Expansorb((R)) PLGA-based microspheres to remote load peptides to create simple and effective long-acting release depots.
引用
收藏
页码:696 / 704
页数:9
相关论文
共 50 条
  • [21] Comparison of drug release from poly(lactide-co-glycolide) microspheres and novel fibre formulations
    Campbell, Christopher S. J.
    Delgado-Charro, M. Begona
    Camus, Olivier
    Perera, Semali
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2016, 30 (08) : 1142 - 1153
  • [22] Sustained release of 17β-estradiol from poly (lactide-co-glycolide) microspheres in vitro and in vivo
    Mogi, T
    Ohtake, N
    Yoshida, M
    Chimura, R
    Kamaga, Y
    Ando, S
    Tsukamoto, T
    Nakajima, T
    Uenodan, H
    Otsuka, M
    Matsuda, Y
    Ohshima, H
    Makino, K
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 17 (03) : 153 - 165
  • [23] A spheres-in-sphere structure for improving protein-loading poly (lactide-co-glycolide) microspheres
    Wang, Mingbo
    Feng, Qingling
    Niu, Xufeng
    Tan, Rongwei
    She, Zhending
    POLYMER DEGRADATION AND STABILITY, 2010, 95 (01) : 6 - 13
  • [24] Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections
    Reinbold, Jochen
    Hierlemann, Teresa
    Hinkel, Helena
    Mueller, Ingrid
    Maier, Martin E.
    Weindl, Tobias
    Schlensak, Christian
    Wendel, Hans Peter
    Krajewski, Stefanie
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2823 - 2832
  • [25] Immobilization of poly(lactide-co-glycolide) microspheres on bone implant materials for antibiotic release and the binding mechanisms
    Wang, Dongwei
    Xiao, Dongqin
    Lu, Mengjie
    Liu, Qing
    Xie, Tao
    Feng, Gang
    Weng, Jie
    Duan, Ke
    RSC ADVANCES, 2020, 10 (12) : 7251 - 7258
  • [26] The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres
    Duncan, G
    Jess, TJ
    Mohamed, F
    Price, NC
    Kelly, SM
    van der Walle, CF
    JOURNAL OF CONTROLLED RELEASE, 2005, 110 (01) : 34 - 48
  • [27] Slow Release Model of Simvastatin Loaded Poly (lactide-co-glycolide) Microparticles for Osteogenesis
    Qutachi, O.
    Shakesheff, K. M.
    Buttery, L. D.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1511 - 1512
  • [28] Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres
    Jiang, WL
    Schwendeman, SP
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (10) : 1558 - 1569
  • [29] The Polymer Free Volume as a Controlling Factor for Drug Release from Poly(lactide-co-glycolide) Microspheres
    Scheler, Stefan
    JOURNAL OF APPLIED POLYMER SCIENCE, 2014, 131 (01)
  • [30] The polymer free volume as a controlling factor for drug release from poly(lactide-co-glycolide) microspheres
    Scheler, S. (stefan.scheler@t-online.de), 1600, John Wiley and Sons Inc (131):